USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	054102/0821			Pages:	4
		Recorded:	10/16/2020
Attorney Dkt #:	VARIOUS
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Total properties: 30

Patent #:	10933112	Issue Dt:	03/02/2021	Application #:	15118031	Filing Dt:	08/10/2016
Publication #:	US20170216391	Pub Dt:	08/03/2017
Title:	HYDROPHILIC ANTIBODY-DRUG CONJUGATES

Patent #:	11202827	Issue Dt:	12/21/2021	Application #:	15411741	Filing Dt:	01/20/2017
Publication #:	US20170137528	Pub Dt:	05/18/2017
Title:	DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

Patent #:	11213584	Issue Dt:	01/04/2022	Application #:	15522614	Filing Dt:	04/27/2017
Publication #:	US20170333556	Pub Dt:	11/23/2017
Title:	DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

Patent #:	11351269	Issue Dt:	06/07/2022	Application #:	15739363	Filing Dt:	12/22/2017
Publication #:	US20180169257	Pub Dt:	06/21/2018
Title:	ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

Patent #:	RE48959	Issue Dt:	03/08/2022	Application #:	15862389	Filing Dt:	01/04/2018
Title:	HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

Patent #:	11331394	Issue Dt:	05/17/2022	Application #:	15897063	Filing Dt:	02/14/2018
Publication #:	US20180326087	Pub Dt:	11/15/2018
Title:	CD19 BINDING AGENTS AND USES THEREOF

Patent #:	11169158	Issue Dt:	11/09/2021	Application #:	15925639	Filing Dt:	03/19/2018
Publication #:	US20180275137	Pub Dt:	09/27/2018
Title:	INTACT MASS DETERMINATION OF PROTEIN CONJUGATED AGENT COMPOUNDS

Patent #:	NONE	Issue Dt:		Application #:	15999346	Filing Dt:	08/17/2018
Publication #:	US20190194338	Pub Dt:	06/27/2019
Title:	BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS

Patent #:	11325980	Issue Dt:	05/10/2022	Application #:	16085511	Filing Dt:	09/14/2018
Publication #:	US20190085091	Pub Dt:	03/21/2019
Title:	COMBINATION THERAPY USING A LIV1-ADC AND A CHEMOTHERAPEUTIC

Patent #:	10912813	Issue Dt:	02/09/2021	Application #:	16128363	Filing Dt:	09/11/2018
Publication #:	US20180369317	Pub Dt:	12/27/2018
Title:	WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

Patent #:	11180552	Issue Dt:	11/23/2021	Application #:	16203809	Filing Dt:	11/29/2018
Publication #:	US20190185561	Pub Dt:	06/20/2019
Title:	CD47 Antibodies and Uses Thereof for Treating Cancer

Patent #:	11607460	Issue Dt:	03/21/2023	Application #:	16226509	Filing Dt:	12/19/2018
Publication #:	US20190184029	Pub Dt:	06/20/2019
Title:	SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGATES AND INHIBITORS OF THE PI3K-AKT MTOR PATHWAY

Patent #:	NONE	Issue Dt:		Application #:	16362125	Filing Dt:	03/22/2019
Publication #:	US20190290775	Pub Dt:	09/26/2019
Title:	Use of Antibody Drug Conjugates Comprising Tubulin Disrupting Agents to Treat Solid Tumor

Patent #:	11078291	Issue Dt:	08/03/2021	Application #:	16411867	Filing Dt:	05/14/2019
Publication #:	US20200002431	Pub Dt:	01/02/2020
Title:	BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	16553525	Filing Dt:	08/28/2019
Publication #:	US20190375841	Pub Dt:	12/12/2019
Title:	ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

Patent #:	11366118	Issue Dt:	06/21/2022	Application #:	16571035	Filing Dt:	09/13/2019
Publication #:	US20200110091	Pub Dt:	04/09/2020
Title:	DETECTION AND TREATMENT OF CD30+ CANCERS

Patent #:	NONE	Issue Dt:		Application #:	16589914	Filing Dt:	10/01/2019
Publication #:	US20200102399	Pub Dt:	04/02/2020
Title:	Methods of Treating Peripheral T Cell Lymphoma Using Anti-CD30 Antibody Drug Conjugate Therapy

Patent #:	11207324	Issue Dt:	12/28/2021	Application #:	16607850	Filing Dt:	10/24/2019
Publication #:	US20200188401	Pub Dt:	06/18/2020
Title:	TREATMENT OF HER2 POSITIVE CANCERS

Patent #:	NONE	Issue Dt:		Application #:	16755091	Filing Dt:	04/09/2020
Publication #:	US20200239585	Pub Dt:	07/30/2020
Title:	MODULATING THE IMMUNE RESPONSE USING ANTIBODY-DRUG CONJUGATES

Patent #:	11795229	Issue Dt:	10/24/2023	Application #:	16755403	Filing Dt:	04/10/2020
Publication #:	US20210221901	Pub Dt:	07/22/2021
Title:	Methods of Reducing Side Effects of Anti-CD30 Antibody Drug Conjugate Therapy

Patent #:	NONE	Issue Dt:		Application #:	16760916	Filing Dt:	05/01/2020
Publication #:	US20220226439	Pub Dt:	07/21/2022
Title:	METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGATE THERAPY

Patent #:	NONE	Issue Dt:		Application #:	16765059	Filing Dt:	05/18/2020
Publication #:	US20200363425	Pub Dt:	11/19/2020
Title:	ACID-MEDIATED ASSAY FOR ANALYZING LIGAND-DRUG CONJUGATES

Patent #:	NONE	Issue Dt:		Application #:	16768020	Filing Dt:	05/28/2020
Publication #:	US20200283540	Pub Dt:	09/10/2020
Title:	HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER

Patent #:	11612666	Issue Dt:	03/28/2023	Application #:	16768027	Filing Dt:	05/28/2020
Publication #:	US20200360532	Pub Dt:	11/19/2020
Title:	PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS

Patent #:	NONE	Issue Dt:		Application #:	16784069	Filing Dt:	02/06/2020
Publication #:	US20200165335	Pub Dt:	05/28/2020
Title:	HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

Patent #:	NONE	Issue Dt:		Application #:	16869322	Filing Dt:	05/07/2020
Publication #:	US20210002380	Pub Dt:	01/07/2021
Title:	Humanized Anti-CD70 Binding Agents and Uses Thereof

Patent #:	10940178	Issue Dt:	03/09/2021	Application #:	16904261	Filing Dt:	06/17/2020
Publication #:	US20200306336	Pub Dt:	10/01/2020
Title:	WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

Patent #:	NONE	Issue Dt:		Application #:	16942647	Filing Dt:	07/29/2020
Publication #:	US20210047404	Pub Dt:	02/18/2021
Title:	CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER

Assignor

Exec Dt:

10/06/2020

Assignee

21823 30TH DRIVE SE

BOTHELL, WASHINGTON 98021

Correspondence name and address
	SEAGEN INC.
	21823 30TH DRIVE SE
	BOTHELL, WA 98021

Search Results as of: 09/24/2024 06:08 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6